Dergiler / Perinatal journal (Online) / 2022 / Cilt: 30 - Sayı: 1

Evaluation of early pregnancy risk factors for venous thromboembolism in Turkish pregnant women: a prospective study

Sayfa
14–20
Yayın Tarihi
2022-10-19
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

In addition, most of these VTE risk factors can be easily corrected and prevented in the pre-gestational phase or first trimester

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Venous thromboembolism (VTE), a condition during pregnancy that manifests as deep vein thrombosis and pulmonary embolism, is the third most common cause of death in 0.01–0.2% pregnant women worldwide each year.
📊
Temel Bulgular & Veri:Because this risk has increased in pregnant women and is treatable, early diagnosis and treatment would save lives.
💡
Sonuç & Katkı:In addition, most of these VTE risk factors can be easily corrected and prevented in the pre-gestational phase or first trimester
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Objective: Venous thromboembolism (VTE), a condition during pregnancy that manifests as deep vein thrombosis and pulmonary embolism, is the third most common cause of death in 0.01–0.2% pregnant women worldwide each year. Because this risk has increased in pregnant women and is treatable, early diagnosis and treatment would save lives. The aim of this study was to evaluate the early pregnancy risk factors for VTE in Turkish pregnant women. Methods: In this prospective study, 480 pregnant women between the ages of 18 and 45 years and who applied to our clinic within their first trimester (4–14 weeks) of pregnancy were enrolled in the study. Because the risk factors of the patients were to be determined, there were no exclusion criteria. The antepartum thromboembolism risk parameters were determined according to Risky Pregnancies Management Guide of Turkish Ministry of Health Guidelines. Results: There were 336 (70%) pregnant women in the low-risk group, 62 (12.9%) in the medium-risk group, and 82 (17.1%) in the high-risk group. The permanent parameters within the groups that determined the risk factors were individually evaluated. Conclusion: Our results indicated that 30% of the study population needed low-molecular-weight heparin (LMWH) prophylaxis, of whom 12.9% were in the medium-risk group, and 17.1% were in the high-risk group. VTE risk occurs from a combination of minor factors, rather than one high-risk factor. In addition, most of these VTE risk factors can be easily corrected and prevented in the pre-gestational phase or first trimester

🔖

Bu Makaleye Atıf Yap

KIRLANGIÇ, M. M., ŞAHİN, M. E. (2022). Evaluation of early pregnancy risk factors for venous thromboembolism in Turkish pregnant women: a prospective study. Perinatal journal (Online), Cilt: 30 - Sayı: 1, 14–20. https://ajindex.com/articles/588305

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (15)

  1. Raskob GE, Angchaisuksiri P, Blanco AN, Buller H, Gallus A, Hunt BJ, et al.
  2. ISTH Steering Committee for World Thrombosis Day. Thrombosis: a major contributor to global disease burden. Arterioscler Thromb Vasc Biol 2014
  3. 2363–71. [PubMed] [CrossRef] 2. White RH. The epidemiology of venous thromboembolism. Circulation 2003
  4. 107(23 Suppl 1):I4–8. [PubMed] [CrossRef] 3. Huang D, Wong E, Zuo ML, Chan PH, Yue WS, Hu HX, et al. Risk of venous thromboembolism in Chinese pregnant women: Hong Kong venous thromboembolism study. Blood Res 2019
  5. 175–80. [PubMed] [CrossRef] 4. Okoroh EM, Azonobi IC, Grosse SD, Grant AM, Atrash HK, James AH. Prevention of venous thromboembolism in pregnancy: a review of guidelines, 2000–2011. J Womens Health (Larchmt) 2012
  6. 611–5. [PubMed] [CrossRef] 5. Bremme KA. Haemostatic changes in pregnancy. Best Pract Res Clin Haematol 2003
  7. 153–68. [PubMed] [CrossRef] 6. Rybstein MD, DeSancho MT. Risk factors for and clinical management of venous thromboembolism during pregnancy. Clin Adv Hematol Oncol 2019
  8. 396–404. [PubMed] 7. T.C. Sa¤l›k Bakanl›¤›. Riskli gebelikler yönetim rehberi. Ankara: T.C. Sa¤l›k Bakanl›¤› Türkiye Halk Sa¤l›¤› Kurumu Kad›n ve Üreme Sa¤l›¤› Daire Baflkanl›¤›
  9. NO, RCOG Green-top Guideline. 37a. Reducing the risk of venous thromboembolism during pregnancy and the puerperium. London: RCOG, 2015. 9. Liu S, Rouleau J, Joseph KS, Sauve R, Liston RM, Young D, et al. Epidemiology of pregnancy associated venous thromboembolism: a population-based study in Canada. J Obstet Gynaecol Canada 2009
  10. 611–20. [PubMed] [CrossRef] 10. Mander R, Smith GD. Saving mothers’ lives (formerly why mothers die): reviewing maternal deaths to make motherhood safer 2003–2005. Midwifery 2008
  11. 8–12. [PubMed] [CrossRef] 11. Pomp ER, Lenselink AM, Rosendaal FR, Doggen CJM. Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study. J Thromb Haemost 2008
  12. 632–7. [PubMed] [CrossRef] 12. Kevane B, Donnelly J, D’Alton M, Cooley S, Preston RJ, Ni Ainle F. Risk factors for pregnancy-associated venous thromboembolism: a review. J Perinat Med 2014
  13. 417–25. [PubMed] [CrossRef] 13. Sahin ME, Col Madendag I. A critical analysis of prophylaxis to avoid venous thromboembolism after cesarean delivery. Ann Med Res 2019
  14. 2648–52. [CrossRef] 14. James AH. Prevention and management of venous thromboembolism in pregnancy. Am J Med 2007
  15. 120(10 Suppl 2):S26–34. [PubMed] [CrossRef] 15. Macklon NS,